PACB Stock News & Catalysts

FEATURED

PacBio Announces Third Quarter 2026 Financial Results

MENLO PARK, Calif., Nov. 04, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB) today announced financial results for the quarter ended September 30, 2026. Recent Business Highlights Delivered total revenue of $40.6

Summary

Nov 4, 2026, 4:05 PM ·Globe Newswire

RECENT

PacBio to Participate in Upcoming Investor Conferences

MENLO PARK, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be participating in the

Oct 27, 2026, 4:05 PM ·Globe Newswire

PacBio and Verily Health Announce Multi-Year Strategic Collaboration to Scale Long-Read Genomics for Biomedical AI

MENLO PARK, Calif. and DALLAS, Oct. 19, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), developer of the world’s most advanced sequencing technologies, and Verily Health Inc., a healthcare data intelligence company,

Oct 19, 2026, 9:05 AM ·Globe Newswire

PacBio to Report Third Quarter 2026 Financial Results on November 4, 2026

MENLO PARK, Calif., Oct. 14, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB) announced today that it will hold its quarterly conference call to discuss its third quarter 2026 financial results on Wednesday, November 4,

Oct 14, 2026, 4:05 PM ·Globe Newswire

PacBio and TychoBio Collaborate to Train AI Models for Rare Disease RNA Therapeutics

MENLO PARK, Calif. and PARIS, Oct. 06, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), developer of the world’s most advanced sequencing technologies, and TychoBio, an AI drug discovery company, today announced a

Oct 6, 2026, 9:05 AM ·Globe Newswire

PacBio to Participate in the Morgan Stanley 24ᵗʰ Annual Global Healthcare Conference

MENLO PARK, Calif., Sept. 03, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will participate in a fireside

Sep 3, 2026, 4:05 PM ·Globe Newswire

PacBio Appoints Mark Van Oene as President and Chief Executive Officer

MENLO PARK, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ:PACB) ("PacBio"), a leading developer of high-quality, highly accurate sequencing solutions, today

Aug 5, 2026, 4:08 PM ·Globe Newswire

PacBio Announces Second Quarter 2026 Financial Results

MENLO PARK, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB) today announced financial results for the quarter ended June 30, 2026. Recent Business Highlights Total revenue of $39.0 million was driven

Aug 5, 2026, 4:05 PM ·Globe Newswire

PacBio Announces Faster Runs, Up to 50% More HiFi Data, and New Compliance Controls for the Vega system

MENLO PARK, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), developer of the world’s most advanced sequencing technologies, today announced the upcoming availability of SPRQ-Nx chemistry and an

Aug 5, 2026, 9:05 AM ·Globe Newswire

PacBio to Participate in the Canaccord Genuity 46th Annual Growth Conference

MENLO PARK, Calif., July 28, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will participate in a fireside

Jul 28, 2026, 4:05 PM ·Globe Newswire

PacBio to Report Second Quarter 2026 Financial Results on August 5, 2026

MENLO PARK, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB) announced today that it will hold its quarterly conference call to discuss its second quarter 2026 financial results on Wednesday, August 5,

Jul 15, 2026, 4:05 PM ·Globe Newswire

PacBio SPRQ-Nx Chemistry Now Shipping Worldwide, Enabling Sub-$300 HiFi Genomes for Large Scale Projects and AI-Enhanced Sequencing

MENLO PARK, Calif., May 26, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), developer of the world's most advanced sequencing technologies, today announced that SPRQ-Nx sequencing chemistry and new multi-use SMRT Cells

May 26, 2026, 9:05 AM ·Globe Newswire

PacBio to Participate in the Jefferies Global Healthcare Conference

MENLO PARK, Calif., May 21, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will participate in a fireside chat

May 21, 2026, 4:05 PM ·Globe Newswire

Blank Bio Announces Seed Financing and Strategic Collaboration with PacBio to Advance RNA Foundation Models for Precision Oncology

Collaboration with PacBio will generate long-read bulk RNA-seq data to advance patient-level prediction from tumor transcriptomes Blank Bio, an applied AI research lab training foundation models for RNA, today

May 19, 2026, 9:00 AM ·Business Wire

HiFi Solves Sub-fertility Consortium in Asia Pacific Reports First Major Study Using HiFi Long-Read Sequencing to Investigate Unexplained Subfertility and Recurrent Pregnancy Loss

MENLO PARK, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), developer of the world's most advanced sequencing technologies, today announced the publication of a preprint describing the first major study

May 11, 2026, 9:05 AM ·Globe Newswire

Pacific Biosciences of California, Inc. PACB · News